Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study.

Min Jee Kim Ye-Jee Kim Dae Hyun Jeong Seon Ok Kim Seokchan Hong Sang Hyoung Park Kyung Wook Jo

Published in: Therapeutic advances in gastroenterology (2024)

In Korean patients with IBD, non-anti-TNF biologics (vedolizumab/ustekinumab) tended to be associated with a lower risk of serious infection or active tuberculosis than anti-TNF-α agents.

Keyphrases

rheumatoid arthritis
patients with inflammatory bowel disease
mycobacterium tuberculosis
hiv aids
emergency department
adverse drug
hiv infected